Cancer

Non-Hodgkin lymphoma survival doubles since early 1970s

More than half of patients diagnosed with Non-Hodgkin Lymphoma (NHL) are now surviving the disease thanks to improved diagnosis and treatment, according to a new report1 from Cancer Research UK.

Cancer

Many options, good outcomes, for early-stage follicular lymphoma

(Medical Xpress) -- A University of Rochester Medical Center study challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient ...

Cancer

New treatment target identified for aggressive lymphomas

Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have identified a possible therapeutic target for two types of very aggressive lymphomas. The CNIC team discovered that the microRNA ...

Cancer

JAK inhibitors associated with aggressive lymphoma

Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.

Cancer

Novel immunotherapy trial for lymphoma offers hope to patients

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are testing a novel cellular immunotherapy approach to treating patients with diffuse large B-cell lymphoma who have ...

page 8 from 23